Feasibility of drugs in Brugada syndrome

Europace. 2018 Jun 1;20(FI1):f137. doi: 10.1093/europace/eux358.

Authors

Ibrahim El-Battrawy^{1

2}, Martin Borggrefe^{1

2}, Siegfried Lang^{1

2}, Xiaobo Zhou^{1

2}, Ibrahim Akin^{1

2}

Affiliations

¹ Faculty of Medicine, First Department of Medicine, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
² DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Germany.

PMID: 29360969
DOI: 10.1093/europace/eux358

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenergic beta-Antagonists
Brugada Syndrome*
Calcium Channel Blockers
Calcium*
Electrocardiography
Humans

Substances

Adrenergic beta-Antagonists
Calcium Channel Blockers
Calcium